(Q44430837)

2 December 2017

title

Serum uric acid in hypertensive patients with and without peripheral arterial disease (English)

1 reference

Cardiology and cardiovascular medicine

2 December 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00093-5

30 December 2023

author name string

Michel Langlois

1

1 reference

2 December 2017

Dirk De Bacquer

2

1 reference

2 December 2017

Daniel Duprez

3

1 reference

2 December 2017

Marc De Buyzere

4

1 reference

2 December 2017

Joris Delanghe

5

1 reference

2 December 2017

Victor Blaton

6

1 reference

2 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12732400

30 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0021915003000935?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00093-5

https://api.elsevier.com/content/article/PII:S0021915003000935?httpAccept=text/plain

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00093-5

30 December 2023

1 reference

2 December 2017

volume

168

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

163-168

1 reference

Uric acid as an independent risk factor in the treatment of hypertension

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid in essential hypertension: an indicator of renal vascular involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Uric acid as a cardiovascular risk factor in arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid and cardiovascular events in successfully treated hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid as a cardiovascular risk factor for heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid is not an independent risk factor for coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Peripheral vascular disease and hypertension: a forgotten association?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Estimation of walking distance in intermittent claudication: need for standardization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Comparison of graded versus constant treadmill test protocols for quantifying intermittent claudication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Hyperuricemia and renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Differential effects of exercise intensity on serum uric acid concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

The effect of cigarette smoking status on six-minute walk distance in patients with intermittent claudication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Identification of uric acid and xanthine oxidase in atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900093-5

Why is training effective in the treatment of patients with intermittent claudication?

7 January 2021

19

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00093-5

30 December 2023

Identifiers

1 reference

2 December 2017

1 reference